Polyneuropathy

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Market Insights, Epidemiology and Market Forecast, 2028 - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 14, 2019
Health, Pharmaceutical, Neurological disorders, Autoimmune diseases, Chronic inflammatory demyelinating polyneuropathy, Polyneuropathy, Peripheral neuropathy, Myelin, Anatomy, Biology

The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Market Insights, Epidemiology and Market Forecast-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Market Insights, Epidemiology and Market Forecast-2028" report has been added to ResearchAndMarkets.com's offering.
  • The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Chronic Inflammatory Demyelinating Polyneuropathy from 2017 to 2028 segmented by seven major markets.
  • According to this research, the global market of Chronic Inflammatory Demyelinating Polyneuropathy was estimated to be USD 473.5 million in 2018.
  • The United States accounts for the largest market size of Chronic Inflammatory Demyelinating Polyneuropathy, in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain), and Japan.

Immunoglobulin Market to Reach $17.50 Bn, Globally, by 2025, at 7.5% CAGR, Says Allied Market Research

Retrieved on: 
Thursday, November 15, 2018
Medicine, Autoimmune diseases, Neurological disorders, Glycoproteins, Chronic inflammatory demyelinating polyneuropathy, Immune system, Biology, Antibody, Polyneuropathy, Health

As per the report, the global immunoglobulin market garnered $9.85 billion in 2017, and is estimated to reach $17.50 billion by 2025, registering a CAGR of 7.5% from 2018 to 2025.

Key Points: 
  • As per the report, the global immunoglobulin market garnered $9.85 billion in 2017, and is estimated to reach $17.50 billion by 2025, registering a CAGR of 7.5% from 2018 to 2025.
  • Surge in geriatric population who are hemophilic, increase in immunoglobulin production using advanced technologies, and use of enhanced purification techniques with better plasma yield drive the growth of the global immunoglobulin market.
  • Furthermore, increase in incidence of diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, and others supplement the market growth.
  • However, stringent government regulations for immunoglobulin products and side effects associated with the use of immunoglobulin hamper the market growth.